(Q44120878)

30 November 2017

Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus (English)

1 reference

familial combined hyperlipidemia

30 November 2017

1 reference

1 reference

1 reference

1 reference

1 reference

11

Jerome I Rotter

1 reference

30 November 2017

Carla J H van der Kallen

1

1 reference

30 November 2017

Christine Voors-Pette

2

1 reference

30 November 2017

Freek G Bouwman

3

1 reference

30 November 2017

Hans A Keizer

4

1 reference

30 November 2017

Jinyan Y Lu

5

1 reference

30 November 2017

René R W J van de Hulst

6

1 reference

30 November 2017

Ruut Bianchi

7

1 reference

30 November 2017

Marc-Jan Janssen

8

1 reference

30 November 2017

Eric T P Keulen

9

1 reference

30 November 2017

Willy D Boeckx

10

1 reference

30 November 2017

Tjerk W A de Bruin

12

1 reference

30 November 2017

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

164

1 reference

30 November 2017

2

1 reference

30 November 2017

337-346

1 reference

Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Genome scan for adiposity in Dutch dyslipidemic families reveals novel quantitative trait loci for leptin, body mass index and soluble tumor necrosis factor receptor superfamily 1A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Mortality among diabetics in a national sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

What if Minkowski had been ageusic? An alternative angle on diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the beta3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Metabolic basis of hypotriglyceridemic effects of insulin in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

The putative role of the hormone-sensitive lipase gene in the pathogenesis of Type II diabetes mellitus and abdominal obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Insulin action in skeletal muscle from patients with NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900109-0

10.1016/S0021-9150(02)00109-0

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference